Imipramine
TCA • Brands: Tofranil
Last reviewed: 2025-09-27
General information
Indicated for: Depression; childhood nocturnal enuresis.
Dosing & forms
- Forms/strengths: —
- Frequency: —
- Food: —
- Typical range: 100–200 mg/day (divided)
Mechanism (brief)
Tricyclic antidepressant; serotonin and norepinephrine reuptake inhibition with anticholinergic activity.
Metabolism & Half‑life
- Metabolism: CYP2D6/CYP1A2 to desipramine.
- Half‑life: ~19–24 h.
Therapeutic Drug Monitoring (TDM)
Recommended: Yes
Reference range: Combined imipramine + desipramine 150–300 ng/mL.
View labelExact
Monitoring highlights
- ECG/QTc baseline and with dose escalations — Baseline and as indicated
- Therapeutic drug monitoring — After steady state and with dose changes
Sources
- Imipramine label — DailyMed (2025)